Literature DB >> 3215695

An international study on the occurrence of multiresistant bacteria and aminoglycoside consumption patterns.

K S Johansen1, M Storgaard, N Carstensen, U Frank, F Daschner.   

Abstract

The correlation between aminoglycoside consumption patterns and the occurrence of aminoglycoside-resistant bacteria from 12 different countries was analyzed. Regional and national data were collected retrospectively and compared. There was evidence of a wide variation of the national aminoglycoside consumption patterns in the different countries. There was a striking correlation of gentamicin resistance and the total national aminoglycoside and national gentamicin consumption. In addition, there was a clear correlation between bacterial resistance inside and outside the hospital to the total amount of aminoglycoside, particularly gentamicin, consumption in hospitals. In a number of countries, an increase in the frequency of gentamicin-resistant bacterial strains could be noticed. For amikacin, only a correlation of staphylococcal resistance in hospitalized patients to the total amount of national aminoglycoside and amikacin consumption could be found.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3215695     DOI: 10.1007/bf01645084

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  37 in total

1.  Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.

Authors:  R C Moellering; C Wennersten; L J Kunz; J W Poitras
Journal:  Am J Med       Date:  1977-06       Impact factor: 4.965

2.  Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli.

Authors:  R L Guerrant; L J Strausbaugh; R P Wenzel; B H Hamory; M A Sande
Journal:  Am J Med       Date:  1977-06       Impact factor: 4.965

3.  Antibiogram of Pseudomonas aeruginosa strains isolated from Zaria, Nigeria.

Authors:  D R Mathur; R V Lawande
Journal:  Public Health       Date:  1985-03       Impact factor: 2.427

4.  An outbreak of infection with a gentamicin and methicillin-resistant Staphylococcus aureus in a neonatal unit.

Authors:  E H Price; A Brain; J A Dickson
Journal:  J Hosp Infect       Date:  1980-09       Impact factor: 3.926

5.  Outbreak of hospital infection with a strain of Staphylococcus aureus resistant to gentamicin and methicillin.

Authors:  D C Shanson; J C Kensit; R Duke
Journal:  Lancet       Date:  1976-12-18       Impact factor: 79.321

6.  An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies.

Authors:  K Crossley; D Loesch; B Landesman; K Mead; M Chern; R Strate
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

7.  Environmental factors contributing to antibiotic resistance.

Authors:  I Phillips
Journal:  Infect Control       Date:  1983 Nov-Dec

8.  A large outbreak of infections caused by a strain of Staphylococcus aureus resistant of oxacillin and aminoglycosides.

Authors:  D E Craven; C Reed; N Kollisch; A DeMaria; D Lichtenberg; K Shen; W R McCabe
Journal:  Am J Med       Date:  1981-07       Impact factor: 4.965

9.  Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center.

Authors:  D N Gerding; T A Larson
Journal:  Am J Med       Date:  1985-07-15       Impact factor: 4.965

10.  Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.

Authors:  L C Preheim; R G Penn; C C Sanders; R V Goering; D K Giger
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

View more
  5 in total

Review 1.  Aminoglycoside therapy. Current use and future prospects.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1990-06-22

2.  Changes in the use of antibacterial drugs in the countries of central and eastern Europe.

Authors:  R A Kiivet; V Bíba; D Enache; V Foltan; J Gulbinovic; N Oltványi; A Orazem; M Popova; L Stika
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Hospital and catchment area antibiotic utilization and bacterial sensitivity in primary infections following gastric surgery in Huddinge, Sweden.

Authors:  S Sjöstedt; P Levin; L Kager; A S Malmborg; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 4.  Bacteraemia in the very old. Features and treatment.

Authors:  L Leibovici
Journal:  Drugs Aging       Date:  1995-06       Impact factor: 3.923

Review 5.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.